These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28559959)

  • 1. Traditional Chinese medicine for lipid metabolism disorders.
    Li Y; Wang X; Shen Z
    Am J Transl Res; 2017; 9(5):2038-2049. PubMed ID: 28559959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-regulating effect of traditional chinese medicine: mechanisms of actions.
    Bei WJ; Guo J; Wu HY; Cao Y
    Evid Based Complement Alternat Med; 2012; 2012():970635. PubMed ID: 22611438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats.
    Guo J; Bei W; Hu Y; Tang C; He W; Liu X; Huang L; Cao Y; Hu X; Zhong X; Cao L
    J Ethnopharmacol; 2011 May; 135(2):299-307. PubMed ID: 21396994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Oral Chinese Herbal Preparations Regulating Intestinal Flora on Lipid Metabolism Disorders in Patients: A Meta-Analysis of Controlled Clinical Studies.
    Gong W; Zhang W; Chang C
    Front Surg; 2022; 9():892438. PubMed ID: 35592117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine.
    Wang T; Huang S; Wu C; Wang N; Zhang R; Wang M; Mao D
    Evid Based Complement Alternat Med; 2021; 2021():6682581. PubMed ID: 33976705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
    Zhou X; Ren F; Wei H; Liu L; Shen T; Xu S; Wei J; Ren J; Ni H
    Lipids Health Dis; 2017 Dec; 16(1):239. PubMed ID: 29228954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.
    Ouyang XJ; Zhang YQ; Chen JH; Li T; Lu TT; Bian RW
    Chin Med J (Engl); 2018 Feb; 131(3):295-300. PubMed ID: 29363644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders.
    Liu M; Shi W; Huang Y; Wu Y; Wu K
    Front Pharmacol; 2023; 14():1134430. PubMed ID: 36937840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A; Fisman EZ; Motro M; Adler Y
    Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoflavones and phytosterols contained in Xuezhikang capsules modulate cholesterol homeostasis in high-fat diet mice.
    Feng D; Sun JG; Sun RB; Ou-Yang BC; Yao L; Aa JY; Zhou F; Zhang JW; Zhang J; Wang GJ
    Acta Pharmacol Sin; 2015 Dec; 36(12):1462-72. PubMed ID: 26592515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive compounds from herbal medicines to manage dyslipidemia.
    Ji X; Shi S; Liu B; Shan M; Tang D; Zhang W; Zhang Y; Zhang L; Zhang H; Lu C; Wang Y
    Biomed Pharmacother; 2019 Oct; 118():109338. PubMed ID: 31545238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
    Dong FH
    Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effect of Chitooligosaccharide Tablets on Lipids in High-Fat Diets Induced Hyperlipidemic Rats.
    Yang D; Hu C; Deng X; Bai Y; Cao H; Guo J; Su Z
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30709014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia.
    Xie W; Zhao Y; Du L
    J Ethnopharmacol; 2012 Mar; 140(2):345-67. PubMed ID: 22306102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin treatment upregulates intestinal lipid secretion pathways in a rodent model of the metabolic syndrome.
    Borthwick F; Mangat R; Warnakula S; Jacome-Sosa M; Vine DF; Proctor SD
    Atherosclerosis; 2014 Jan; 232(1):141-8. PubMed ID: 24401228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
    Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.